ReviewFrontiers in pharmacology2020

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.

Andrey A Poloznikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.